Bookmark

Add to MyYahoo RSS

Ranbaxy Laboratories News

News on Ranbaxy Laboratories (Ticker: RBXLY) continually updated from thousands of sources around the net.

Wednesday | Mydigitalfc.com

Pharma shares buck stock market trend, lead gainers

Drug makers rise, bucking the stock market trend as investors seek defensives. Ranbaxy Laboratories is up 4 percent, while Sun Pharmaceutical Industries gains 4.2 percent after marking an all-time high of 839 rupees.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry, Sun Chemical, Chemicals

Wed Aug 13, 2014

The Telegraph

Sun bid to address monopoly concern

Mumbai, Aug. 13: Sun Pharma today said it was in discussion with the Competition Commission of India to allay apprehensions about the impact of its acquisition of Ranbaxy Laboratories on the domestic pharmaceutical sector.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

Fri Aug 08, 2014

The Indian Express

Sun Pharma-Ranbaxy Lab deal comes under CCI scanner

Competition Commission of India would take a final view on the deal after receiving details from them and could seek more information if it is not satisfied with the responses.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

Mon Aug 04, 2014

StockMarketsReview.com

Ranbaxy Laboratories 1QFY2015 performance highlights and results update

For 1QFY2015, Ranbaxy Laboratories posted a lower-than-expected set of results. For the period, sales came in at Rs.2,372cr V/s Rs.2,633cr in 2QFY2014, ie a yoy de-growth of 9.9%.

Comment?

Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry, World News, India

Wed Jul 30, 2014

Hindustan Times

Sun Pharma to seek shareholders nod for Ranbaxy acquisition

Mumbai-based Sun Pharmaceutical Industries will seek shareholders nod for its $4 billion acquisition of Ranbaxy Laboratories in a court convened meeting on August 22. In a filing to the BSE, the company said the meeting would be held at Vadodara on August 22, 2014.

Comment?

Related Topix: World News, India, Sun Chemical, Chemicals, Biotech, Ranbaxy Laboratories, Healthcare Industry, Asia

Tue Jul 29, 2014

Express India

Ranbaxy Laboratories quarterly net loss narrows to Rs 185.92 cr

Drug firm Ranbaxy Laboratories today reported consolidated net loss of Rs 185.92 crore for the quarter ended June 30, 2014.

Comment?

Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry, Food and Drug Administration

Mon Jul 28, 2014

Pharmaceutical Engineering

Interview with Dinesh Thakur, ISPE Annual Meeting Keynote Speaker

Unprecedented regulatory actions such as the invocation of the Application Integrity Policy, a highly restrictive and cumbersome Consent Decree, and successive import alerts have emphasized the risks to the pharmaceutical supply chain, especially when sourcing API, intermediates, excipients from countries like India and China.

Comment?

Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry, Outsourcing, University of New Hampshire

Thu Jul 24, 2014

Canada NewsWire

Cipher Pharmaceuticals and Ranbaxy Announce Distribution Agreement for Isotretinoin Product in Brazil

Cipher will supply the product to Ranbaxy and product manufacturing will be done by Cipher's partner, Galephar Pharmaceutical Research.

Comment?

Related Topix: Medicine, Accutane, Isotretinoin (generic), Biotech, Marketing

•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••